Other Information
+Added: Trading Arrangements
+Added: During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Exhibit Description Filed Herewith
9 unchanged sentences
(incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on January 24, 2022).
−Removed: 10.1 Commitment Letter, dated as of January 29, 2023, by and between Core Scientific, Inc.
−Removed: Riley Commercial Capital LLC (incorporated by reference to Exhibit 10.01 to the Company’s Current Report on Form 8-K (File No.:
−Removed: 001-40046), filed with the SEC on February 7, 2023).
−Removed: 10.2 Replacement DIP Credit Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No.:
−Removed: 001-40046), filed with the SEC on March 2, 2023).
+Added: 10.1 First Amendment to Replacement DIP Credit Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No.:
+Added: 001-40046), filed with the SEC on July 6, 2023).
31.1 Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
13 unchanged sentences
CORE SCIENTIFIC, INC.
−Removed: May 12, 2023 By:
+Added: August 4, 2023 By:
/s/ Denise Sterling
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.